Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats

• Martin F. J. Perescis ,

  * E-mail: m.perescis@has.nl

  Affiliations Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands, HAS University of Applied Sciences, ‘s-Hertogenbosch, The Netherlands

  http://orcid.org/0000-0001-5540-4983

  ⨯
• Natasja de Bruin,

  Current address: Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine & Pharmacology TMP, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany

  Affiliation Abbott Healthcare Products BV (formerly Solvay Pharmaceuticals), Weesp, The Netherlands

  ⨯
• Liesbeth Heijink,

  Current address: Department of Drug Discovery Science & Management—Europe, Astellas Pharma Europe R&D, Leiden, The Netherlands

  Affiliation Abbott Healthcare Products BV (formerly Solvay Pharmaceuticals), Weesp, The Netherlands

  ⨯
• Chris Kruse,

  Current address: Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands

  Affiliation Abbott Healthcare Products BV (formerly Solvay Pharmaceuticals), Weesp, The Netherlands

  ⨯
• Lyudmila Vinogradova,

  Affiliation Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia

  ⨯
• Annika Lüttjohann,

  Affiliation Institut für Physiologie I, Westfälische Wilhelms Universität Münster, Münster, Germany

  ⨯
• Gilles van Luijtelaar,

  Affiliation Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands

  ⨯
• Clementina M. van Rijn

  Affiliation Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands

  ⨯